Jefferies has reiterated its Buy rating on PB Fintech, with a target price of ₹1,800, reflecting confidence in the company’s growth trajectory. The brokerage firm highlighted that PB Fintech’s management has clarified its plans for a one-time investment of up to $100 million to acquire a 20-35% stake in a new healthcare venture.
This clarification addresses key concerns around the company’s balance sheet while ensuring it remains asset-light. Jefferies noted that PB Fintech continues to be the preferred play in India’s insurance growth market, with its core engineering business remaining in a high-growth orbit.
The company’s investment strategy, alongside its stable balance sheet, strengthens its position in India’s rapidly expanding insurance sector.
Disclaimer: Stock market investments are subject to market risks. The information provided in this article is for informational purposes only and should not be construed as investment advice or a recommendation. Readers are advised to seek independent financial advice before making any investment decisions. The author and the publication are not responsible for any investment losses incurred based on the information provided in this article.
